1887

Abstract

To present short protein sequences to the host immune system a foreign epitope has been expressed on the surface of the adenovirus virion as part of the hexon. As the trimeric hexon constitutes 240 out of the 252 capsomers of the virus, the foreign epitope is repeated 720 times on the virion surface. An eight amino acid sequence from the major antigenic site in the VP1 capsid protein of poliovirus type 3 was engineered into two regions of the adenovirus type 2 hexon. The two loop regions chosen to accommodate the foreign sequences are exposed on the surface of the virion, show sequence variation between serotypes and are the sites of interaction with neutralizing antibodies. Virus with substitutions in loop I had wild-type growth characteristics, whereas virus with substitutions in loop II grew poorly. Adenoviruses with poliovirus sequences in loop I were recognized and efficiently neutralized by antisera specific for the poliovirus sequence; an antiserum raised against the adenovirus with the poliovirus insert specifically recognized the VP1 capsid protein of poliovirus type 3. It is therefore feasible to alter the surface properties of the adenovirus virion and in doing so to manipulate the immune response to this virus.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-1-133
1994-01-01
2022-05-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/1/JV0750010133.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-1-133&mimeType=html&fmt=ahah

References

  1. Adam E., Lengyel A., Takacs M., Erdei J., Fachet J., Nasz I. 1986; Grouping of monoclonal antibodies to adenovirus hexons by their cross-reactivity. Archives of Virology 87:61–71
    [Google Scholar]
  2. Boursnell M. E. G., Mautner V. 1981; Recombination in adenovirus: crossover sites in intertypic recombinants are located in regions of homology. Virology 112:198–209
    [Google Scholar]
  3. Burke K. L., Dunn G., Ferguson M., Minor P. D., Almond J. W. 1988; Antigen chimaeras of poliovirus as potential new vaccines. Nature; London: 32281–82
    [Google Scholar]
  4. Burke K. L., Evans D. J., Jenkins O., Meredith J., D’Souza E. D. A., Almond J. W. 1989; A cassette vector for the construction of antigen chimaeras of poliovirus. Journal of General Virology 70:2475–2479
    [Google Scholar]
  5. Colbere-Garapin F., Christodoulou C., Crainic R., Garapin A. C. 1988; Addition of a foreign oligopeptide to the major capsid protein of poliovirus. Proceedings of the National Academy of Sciences U.S.A.: 858668–8672
    [Google Scholar]
  6. Dedieu J. F., Ronco J., Vanderwerf S., Hogle J. M., Henin Y., Girard M. 1992; Poliovirus chimeras expressing sequences from the principal neutralization domain of human immunodeficiency virus type-1. Journal of Virology 66:3161–3167
    [Google Scholar]
  7. Evans D. M. A., Minor P. D., Schild G. C., Almond J. W. 1983; Critical role of an eight amino acid sequence of VP1 in the neutralization of poliovirus type 3. Nature; London: 304459–462
    [Google Scholar]
  8. Evans D. M. A., McKeating J., Mcreating J., Meredith J. M., Burke K. L., Katrak K., John A., Ferguson M., Minor P. D., Weiss R. A., Almond J. W. 1989; An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature; London: 339385–388
    [Google Scholar]
  9. Ferguson M., Evans D. M. A., Magrath D. I., Minor P. D., Almond J. W., Schild G. C. 1985; Induction by synthetic peptides of broadly reactive, type-specific neutralizing antibody to poliovirus type 3. Virology 143:505–515
    [Google Scholar]
  10. Ginsberg H. S. 1984 The Adenoviruses New York & London: Plenum Press;
    [Google Scholar]
  11. Graham F. L. 1990; Adenoviruses as expression vectors and recombinant vaccines. Trends in Biotechnology 8:85–87
    [Google Scholar]
  12. Graham F. L., Smiley J., Russell W. C., Nairn R. 1977; Characteristics of a human cell line transformed by DNA from human adenovirus type 5. Journal of General Virology 36:59–72
    [Google Scholar]
  13. Hay R. T., Stow N. D., McDougall I. M. 1984; Replication of adenovirus mini-chromosomes. Journal of Molecular Biology 175:493–510
    [Google Scholar]
  14. Hierholzer J. C., Wigand R., Anderson L. J., Adrian T., Gold J. W. M. 1988; Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (type 43-47). Journal of Infectious Diseases 158:804–813
    [Google Scholar]
  15. Jenkins O., Cason J., Burke K. L., Lunney D., Gillen A., Patel D., McCance D. J., Almond J. W. 1990; An antigen chimera of poliovirus induces antibodies against human papillomavirus type 16. Journal of Virology 64:1201–1206
    [Google Scholar]
  16. Kinloch R., Mackay N., Mautner V. 1984; Adenovirus hexon. Sequence comparison of subgroup C serotypes 2 and 5. Journal of Biological Chemistry 259:6431–6436
    [Google Scholar]
  17. Kitson J. D., Burke K. L., Pullen L. A., Belsham G. J., Almond J. W. 1991; Chimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs. Journal of Virology 65:3068–3075
    [Google Scholar]
  18. Lemon S. M., Barclay W., Ferguson M., Murphy P., Jing L., Burke K., Wood D., Katrak K., Sangar D., Minor P. D., Almond J. W. 1992; Immunogenicity and antigenicity of chimeric picornaviruses which express hepatitis-A virus (HAV) peptide sequences - evidence for a neutralization domain near the amino terminus of VP1 of HAV. Virology 188:285–295
    [Google Scholar]
  19. Martin A., Wychowski C., Couderc T., Crainic R., Hogle J., Girard M. 1988; Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice. EMBO Journal 7:2839–2847
    [Google Scholar]
  20. Mautner V., Boursnell M. E. G. 1983; Recombination in adenovirus: DNA sequence analysis of crossover sites in intertypic recombinants. Virology 131:1–10
    [Google Scholar]
  21. Minor P. D., Schild G. C., Bootman J., Evans D. M. A., Ferguson M., Reeve P., Spitz M., Stanway G., Cann A. J., Hauptmann R., Clarke L. D., Mountford R. C., Almond J. W. 1983; Location and primary structure of a major antigenic site for poliovirus neutralisation. Nature; London: 301674–679
    [Google Scholar]
  22. Minor P. D., Ferguson M., Katrak K., Wood D., John A., Howlett J., Dunn G., Burke K., Almond J. W. 1990; Antigenic structure of chimeras of type 1 and type 3 polioviruses involving antigenic site 1. Journal of General Virology 71:2543–2551
    [Google Scholar]
  23. Minor P. D., Ferguson M., Katrak K., Wood D., John A., Howlett J., Dunn G., Burke K., Almond J. W. 1991; Antigenic structure of chimeras of type 1 and type 3 polioviruses involving antigenic sites 2, 3 and 4. Journal of General Virology 72:2475–2481
    [Google Scholar]
  24. Murdin A. D., Wimmer E. 1989; Construction of a poliovirus type 1 /type 2 antigenic hybrid by manipulation of neutralization antigenic site II. Journal of Virology 63:5251–5257
    [Google Scholar]
  25. Murdin A. D., Kameda A., Murray M. G., Wimmer E. 1991a; Phenotypic characterization of antigenic hybrids of poliovirus. Microbial Pathogenesis 10:39–45
    [Google Scholar]
  26. Murdin A. D., Mirzayan C., Kameda A., Wimmer E. 1991b; The effect of site and mode of expression of a heterologous antigenic determinant on the properties of poliovirus hybrids. Microbial Pathogenesis 10:27–37
    [Google Scholar]
  27. Murdin A. D., Lu H., Murray M. G., Wimmer E. 1992; Poliovirus antigenic hybrids simultaneously expressing antigenic determinants from all three serotypes. Journal of General Virology 73:607–611
    [Google Scholar]
  28. Murray M. G., Bradley J., Yang X. F., Wimmer E., Moss E. G., Racaniello V. R. 1988a; Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I. Science 241:213–215
    [Google Scholar]
  29. Murray M. G., Kuhn R. J., Arita M., Kawamura N., Nomoto A., Wimmer E. 1988b; Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys. Proceedings of the National Academy of Sciences U.S.A.: 853203–3207
    [Google Scholar]
  30. Reimann B. Y., Zell R., Kandolf R. 1991; Mapping of a neutralizing antigenic site of coxsackievirus-B4 by construction of an antigen chimera. Journal of Virology 65:3475–3480
    [Google Scholar]
  31. Roberts M. M., White J. L., Grütter M. G., Burnett R. M. 1986; Three-dimensional structure of the adenovirus major coat protein hexon. Science 232:1148–1151
    [Google Scholar]
  32. Russell W. C., Patel G., Precious B., Sharp I., Gardner P. S. 1981; Monoclonal antibodies against adenovirus type 5: preparation and preliminary characterization. Journal of General Virology 56:393–408
    [Google Scholar]
  33. Toogood C. I. A., Hay R. T. 1988; DNA sequence of the adenovirus type 41 hexon gene and predicted structure of the protein. Journal of General Virology 69:2291–2301
    [Google Scholar]
  34. Toogood C. I. A., Murali R., Burnett R. M., Hay R. T. 1989; The adenovirus type 40 hexon: sequence, predicted structure and relationship to other adenovirus hexons. Journal of General Virology 70:3203–3214
    [Google Scholar]
  35. Toogood C. I. A., Crompton J., Hay R. T. 1992; Antipeptide antisera define neutralizing epitopes on the adenovirus hexon. Journal of General Virology 73:1429–1435
    [Google Scholar]
  36. Willcox N., Mautner V. 1976a; Antigenic determinants of adenovirus capsids. I. Measurement of antibody cross reactivity. Journal of Immunology 116:19–24
    [Google Scholar]
  37. Willcox N., Mautner V. 1976b; Antigenic determinants of adenovirus capsids. II. Homogeneity of hexons, and accessibility of their determinants, in the virion. Journal of Immunology 116:25–29
    [Google Scholar]
  38. Williams J. F. 1970; Enhancement of adenovirus plaque formation on HeLa cells by magnesium chloride. Journal of General Virology 9:251–255
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-1-133
Loading
/content/journal/jgv/10.1099/0022-1317-75-1-133
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error